11468204

Source:http://linkedlifedata.com/resource/pubmed/id/11468204

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0020542, umls-concept:C0529793
pubmed:issue	4
pubmed:dateCreated	2001-7-24
pubmed:abstractText	This study investigated the effect of the phosphodiesterase 5 inhibitor sildenafil on the pulmonary vascular response to hypoxia in humans and mice.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0147763
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclic GMP, http://linkedlifedata.com/resource/pubmed/chemical/NOS3 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type II, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type III, http://linkedlifedata.com/resource/pubmed/chemical/Nos3 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Phosphodiesterase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Piperazines, http://linkedlifedata.com/resource/pubmed/chemical/Purines, http://linkedlifedata.com/resource/pubmed/chemical/Sulfones, http://linkedlifedata.com/resource/pubmed/chemical/sildenafil
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1524-4539
pubmed:author	pubmed-author:AldashevAA, pubmed-author:KojonazarovBB, pubmed-author:MaripovAA, pubmed-author:MasonN ANA, pubmed-author:MirrakhimovM MMM, pubmed-author:MorrellN WNW, pubmed-author:SadykovAA, pubmed-author:WilkinsM RMR, pubmed-author:ZhaoLL
pubmed:issnType	Electronic
pubmed:day	24
pubmed:volume	104
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	424-8
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:11468204-Adolescent, pubmed-meshheading:11468204-Adult, pubmed-meshheading:11468204-Animals, pubmed-meshheading:11468204-Anoxia, pubmed-meshheading:11468204-Cyclic GMP, pubmed-meshheading:11468204-Double-Blind Method, pubmed-meshheading:11468204-Genotype, pubmed-meshheading:11468204-Heart Ventricles, pubmed-meshheading:11468204-Humans, pubmed-meshheading:11468204-Hypertension, Pulmonary, pubmed-meshheading:11468204-Hypertrophy, pubmed-meshheading:11468204-Lung, pubmed-meshheading:11468204-Mice, pubmed-meshheading:11468204-Mice, Inbred C57BL, pubmed-meshheading:11468204-Mice, Knockout, pubmed-meshheading:11468204-Nitric Oxide Synthase, pubmed-meshheading:11468204-Nitric Oxide Synthase Type II, pubmed-meshheading:11468204-Nitric Oxide Synthase Type III, pubmed-meshheading:11468204-Phosphodiesterase Inhibitors, pubmed-meshheading:11468204-Piperazines, pubmed-meshheading:11468204-Pulmonary Artery, pubmed-meshheading:11468204-Purines, pubmed-meshheading:11468204-Sulfones, pubmed-meshheading:11468204-Ventricular Function, Right
pubmed:year	2001
pubmed:articleTitle	Sildenafil inhibits hypoxia-induced pulmonary hypertension.
pubmed:affiliation	Section on Clinical Pharmacology, Imperial College School of Medicine, Hammersmith Hospital, London, UK.
pubmed:publicationType	Journal Article, Clinical Trial, In Vitro, Randomized Controlled Trial, Research Support, Non-U.S. Gov't